Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial

類似資料

• Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
  著者:: Wechsler, M, 等
  出版事項: (2017)
• OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
  著者:: Wechsler, M, 等
  出版事項: (2017)
• Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
  著者:: Benjamin Terrier, 等
  出版事項: (2023-07-01)
• Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
  著者:: Ravi Ranjan Pradhan, 等
  出版事項: (2019-01-01)
• Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
  著者:: Giuseppe A. Ramirez, 等
  出版事項: (2022-12-01)